New World Advisors »

Summit Therapeutics shares owned by New World Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by New World Advisors from 13F filings

Historical chart of New World Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by New World Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by New World Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $238k 16k 14.57

More positions owned by New World Advisors

TJX Companies (TJX)
Ishares Tr Core S&p500 Etf (IVV)
Baillie Gifford Etf Tr Intl Concntr Grw
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Eafe Value Etf (EFV)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ark Etf Tr Innovation Etf (ARKK)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Micron Technology (MU)

View all positions for New World Advisors

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics